Regeneron Pharmaceuticals Other Non-Current Liabilities 2010-2025 | REGN
Regeneron Pharmaceuticals other non-current liabilities for the quarter ending March 31, 2025 were $1.674B, a 84.3% increase year-over-year.
- Regeneron Pharmaceuticals other non-current liabilities for 2024 were $1.571B, a 83.98% increase from 2023.
- Regeneron Pharmaceuticals other non-current liabilities for 2023 were $0.854B, a 33.87% increase from 2022.
- Regeneron Pharmaceuticals other non-current liabilities for 2022 were $0.638B, a 6.2% decline from 2021.